Regeneron Pharmaceuticals, Inc.

Report date
9/30/2026
Quarter
2026 Q3
Filed
11/10/2026
Shares
75,878
Value ($000)
57,536
Weight
1.0%
2013 Q4 - 2026 Q3 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).